{"id":"NCT01100502","sponsor":"Seagen Inc.","briefTitle":"A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of SGN-35 and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Patients at High Risk of Residual Hodgkin Lymphoma Following Autologous Stem Cell Transplant","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-04-30","primaryCompletion":"2014-08-31","completion":"2020-04-27","firstPosted":"2010-04-09","resultsPosted":"2015-11-11","lastUpdate":"2021-05-14"},"enrollment":329,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Disease, Hodgkin"],"interventions":[{"type":"DRUG","name":"brentuximab vedotin","otherNames":["SGN-35","Adcetris"]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Brentuximab vedotin","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, placebo-controlled, multicenter phase 3 trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) and best supportive care (BSC) compared to placebo and BSC in treatment of residual Hodgkin lymphoma (HL) following autologous stem cell transplant (ASCT).","primaryOutcome":{"measure":"Progression-free Survival by Independent Review","timeFrame":"Up to approximately 4 years","effectByArm":[{"arm":"Brentuximab Vedotin","deltaMin":42.9,"sd":null},{"arm":"Placebo","deltaMin":24.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":87,"countries":["United States","Bulgaria","Czechia","France","Germany","Hungary","Italy","Poland","Romania","Russia","Serbia","Spain","United Kingdom"]},"refs":{"pmids":["25796459","30266774"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":160},"commonTop":["Peripheral sensory neuropathy","Upper respiratory tract infection","Neutropenia","Fatigue","Cough"]}}